GENOMIC ANALYSIS
RNA was extracted from 3 × 10 6 of SK-N-MC cells with High Pure RNA isolation kit (Roche Diagnostics). 5 g of RNA acquired from SK-N-MC cells were amplified and labeled with Cy3 (Agilent Technologies Inc.) to produce labeled cRNA using Agilent low RNA input fluorescent linear amplification kits following the manufacturers' protocol. After the amplification and labeling, the dye-incorporation ratio was determined using an Agilent 2100 Bioanalyser (Agilent Technologies Inc.). After washing and drying, the slides were scanned using an Agilent G2565BA scanner and the raw data were generated using Feature Extraction vs. 9.5 Image Analysis Software (Agilent Technologies Inc.). The analysis of raw data was generated with GeneSpring GX (Agilent Technologies Inc.). Data from all samples were subjected to quantile normalization [1] and the expression profiles for probes corresponding to replicated genes were averaged. Differential expression analysis for treated and control cells was performed using the rank product method [2] . A permutation-based estimation procedure with 100 random iterations was then used to * Correspondence to: Javier S. Burgos, PhD, Neuron BIO, BioPharma Division, Parque Tecnológico de Ciencias de la Salud, Edificio BIC, Avda. de la Innovación 1, 18100 Armilla, Granada, Spain. Tel.: +34 958 750 598; Fax: +34 958 750 459; E-mail: jburgos@neuronbio.com. estimate the false discovery rate (FDR) value. Biological functions associated with differentially expressed genes were obtained by examining the Gene Ontology (GO) Biological Processes that were enriched in the list of genes. Correction for multiple hypothesis testing was conducted using the FDR method of Benjamini & Hochberg [3] . Gene networks and canonical pathways representing key genes were identified using Ingenuity Pathways Analysis (IPA, Ingenuity Systems Inc.) database. Briefly, the data set containing gene identifiers and corresponding fold changes was uploaded into the web-delivered application and each gene identifier was mapped to its corresponding gene object in the Ingenuity Pathways Knowledge Base (IPKB). The functional analysis identified the biological functions and/or diseases that were most significant to the data sets. Fisher's exact test was performed to calculate a p-value determining the probability that each biological function and/or disease assigned to the data set was due to chance alone. The data set was mined for significant pathways with the IPA library of canonical pathways and networks were generated by using IPA as graphical representations of the molecular relationships between genes and gene products. Differentially expressed genes were then examined, based on their GO annotation [4] . IPA was used to investigate the biological importance of the observed genome-wide changes by categorizing the obtained data into biological functions (Supplementary Table 1 set, with the corresponding gene identifiers and fold changes, was uploaded into the web application and each gene identifier mapped to its corresponding gene object in the IPKB. Functional analysis identified the biological functions and/or diseases most significantly associated with the data sets. These included lipid metabolism, small molecule biochemistry, and metabolic disease. Network analysis was then performed to identify the relationships among the involved genes ( Supplementary Fig. 1 ).
PROTEOMIC ANALYSIS
Differentially expressed proteins were examined using the GO-Tree Machine (GOTM, http://bioinfo.vanderbilt.edu/gotm/), a GO enrichment analysis tool that compares a protein/gene list with all GO categories to identify those associated with increased protein production. The results obtained after simvastatin treatment are summarized in Supplementary Table 2 . Categories showing significantly different expressions after the 4 M dataset were: lipid biosynthesis, acyl group transfer and chromatin and chromosome organization.
IN VITRO qRT-PCR
Total RNA isolated with the High Pure RNA isolation kit (Roche) was subjected (600 ng RNA) to reverse transcription using the RNA to cDNA Kit (Applied Biosystems). cDNA was mixed with the TaqMan Gene Expression Master Mix (Applied Biosystems) and the Taqman Gene Expression Assay probe (DHCR24 Hs00207388 m1; Applied Biosystems). PCR (95 • C for 10 min plus 40 cycles of 95 • C for 15 s, 60 • C for 1 min, and a final step at 25 • C for 1 min) was performed in a 7500 Fast Real-Time PCR System (Applied Biosystems). The relative quantity was determined by the ddCt method using SDS v1.4 software. gapdh was used as the housekeeping gene; its expression did not change at any time in PCR experiments using the Taqman Gene Expression Assay probe Hs99999905 m1 (Applied Biosystems).
IN VIVO RT-qPCR
All experiments were performed in accordance with the guidelines of the European Union, under the supervision of veterinary staff, and were approved by the ethics committees of Neuron BIO and the University of Granada. Male C57BL6 mice from Charles River (Barcelona, Spain), aged 18 weeks, were divided into two groups. All were housed in an air-conditioned room under a 12 L/12D photoperiod until sacrifice and had free access to water and food. Non-fasted mice were i.p-treated with a single dose of 50 mg/kg of simvastatin (12.5 mg/mL in methylcellulose 0.5% [in saline]) (dose was selected from our previous published data [5] ). Control animals received an equivalent volume of the vehicle. At 32 h post-injection, mice were deeply anaesthetized with fluorane (2% with O 2 at 0.2 L/min and air at 1.5 L/min) and the whole brain extracted in RNase free conditions and conserved at −80 • C until RNA extraction. The whole brain was homogenized in Mili-Q water (1 : 1 dilution) and RNA isolated from 45 mg of the homogenate using the High Pure RNA Isolation Kit (Roche). The RNA obtained (500 ng) was subjected to reverse transcription using the RNA to cDNA Kit (Applied Biosystems). cDNA was mixed with the TaqMan Gene Expression Master Mix (Applied Biosystems) and the Taqman Gene Expression Assay probe (DHCR24 Mm00519071 m1 as above in a 7500 Fast Real-Time PCR thermocycler (Applied Biosystems). The relative quantity was determined by the ddCt method using SDS v1.4 software; 18S was the housekeeping gene; its expression did not change at any time in PCR experiments using the Taqman Gene Expression Assay probe Hs99999901 s1; (Applied Biosystems).
IMMUNODETECTION OF SELADIN-1
Paraffin wax-embedded sections of whole brains were deparaffinated and dehydrated. Immunohistochemical labeling was performed by incubating the samples overnight with DHCR24/seladin-1 rabbit monoclonal antibody (Cell Signaling Technology) Supplementary Table 2 Gene Ontology (GO) analysis. Differentially expressed proteins were examined with the GO-Tree Machine (GOTM, http://bioinfo. vanderbilt.edu/gotm/). The list of GO categories enriched in proteins in the proteomic profiles obtained with the 0.4 and 4 M simvastatin-treated cells is shown. The ratio of enrichment indicates the strength of the association; the p value (adjusted by multiple test adjustment) measures its significance 
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Supplementary Diagram 1. Overview of the cholesterol biosynthesis pathway (adapted from [6] ). Cholesterol is synthesized from acetyl-CoA. 3-hydroxy-3-methylglutaryl CoA reductase (HMGCR) is the rate limiting enzyme since the reduction of 3-hydroxy-3-methylglutaryl CoA to mevalonate is a determining step in cholesterol formation. This enzyme is the first target for simvastatin (in orange). The last step of the cholesterol biosynthesis pathway is catalyzed by seladin-1 (DHCR24) (in blue). Simvastatin inhibits HMGCR at the beginning of the pathway. It also provokes the overexpression of seladin-1. diluted 1 : 50 in 10% blocking solution (BSA 1% in PBS-Tween 0.05%) at 4 • C, and then with goat anti-rabbit biotinylated antibodies (Jackson ImmunoResearch) diluted 1 : 500 in PBS at room temperature for 1 h. The samples were then processed using the Elite ABC Perox Kit (Vector Laboratories); the peroxidase reaction product was detected using 3,3 -diaminobenzidinetetrahydrochloride. Finally, samples were counterstained with Mayer's hematoxylin for 5 min and rinsed under running tap water. For negative controls, consecutive sections of each sample were incubated as describe above but without the primary or secondary antibodies. Brains of vehicle-treated mice were included to monitor the specificity of the staining.
